These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 32122871)

  • 1. Virtual screening of antitumour phytochemical against peroxisome proliferators activated receptor proteins PPARs.
    Riaz S; Ahmed M; Hasnain S
    Pak J Pharm Sci; 2020 Jan; 33(1(Supplementary)):379-383. PubMed ID: 32122871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An update about the crucial role of stereochemistry on the effects of Peroxisome Proliferator-Activated Receptor ligands.
    Laghezza A; Piemontese L; Tortorella P; Loiodice F
    Eur J Med Chem; 2019 Aug; 176():326-342. PubMed ID: 31112893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of novel PPAR ligands by a virtual screening approach based on pharmacophore modeling, 3D shape, and electrostatic similarity screening.
    Markt P; Petersen RK; Flindt EN; Kristiansen K; Kirchmair J; Spitzer G; Distinto S; Schuster D; Wolber G; Laggner C; Langer T
    J Med Chem; 2008 Oct; 51(20):6303-17. PubMed ID: 18821746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular recognition of docosahexaenoic acid by peroxisome proliferator-activated receptors and retinoid-X receptor alpha.
    Gani OA; Sylte I
    J Mol Graph Model; 2008 Sep; 27(2):217-24. PubMed ID: 18547851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Peroxisome Proliferator-Activated Receptors (PPARs) in Energy Homeostasis of Dairy Animals: Exploiting Their Modulation through Nutrigenomic Interventions.
    Hassan FU; Nadeem A; Li Z; Javed M; Liu Q; Azhar J; Rehman MS; Cui K; Rehman SU
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluorescence resonance energy transfer techniques to study ligand-mediated interactions of PPARs with coregulators.
    Mitro N; Godio C; Crestani M
    Methods Mol Biol; 2013; 952():219-27. PubMed ID: 23100236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Docking and molecular dynamics simulations of peroxisome proliferator activated receptors interacting with pan agonist sodelglitazar.
    Liu XY; Wang RL; Xu WR; Tang LD; Wang SQ; Chou KC
    Protein Pept Lett; 2011 Oct; 18(10):1021-7. PubMed ID: 21592078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Anticancer Potential of Peroxisome Proliferator-Activated Receptor Antagonists.
    De Lellis L; Cimini A; Veschi S; Benedetti E; Amoroso R; Cama A; Ammazzalorso A
    ChemMedChem; 2018 Feb; 13(3):209-219. PubMed ID: 29276815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, sythesis and evaluation of a series of 3- or 4-alkoxy substituted phenoxy derivatives as PPARs agonists.
    Zhang J; Wang XJ; Liu X; Huan Y; Yang MM; Shen ZF; Jia WQ; Jing Z; Wang SQ; Xu WR; Cheng XC; Wang RL
    Oncotarget; 2017 Mar; 8(13):20766-20783. PubMed ID: 28186999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peroxisome proliferators and peroxisome proliferator activated receptors (PPARs) as regulators of lipid metabolism.
    Latruffe N; Vamecq J
    Biochimie; 1997; 79(2-3):81-94. PubMed ID: 9209701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peroxisome proliferator-activated receptors and their relevance to dermatology.
    Friedmann PS; Cooper HL; Healy E
    Acta Derm Venereol; 2005; 85(3):194-202. PubMed ID: 16040401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peroxisome proliferator-activated receptor structures: ligand specificity, molecular switch and interactions with regulators.
    Zoete V; Grosdidier A; Michielin O
    Biochim Biophys Acta; 2007 Aug; 1771(8):915-25. PubMed ID: 17317294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacophore modeling and parallel screening for PPAR ligands.
    Markt P; Schuster D; Kirchmair J; Laggner C; Langer T
    J Comput Aided Mol Des; 2007; 21(10-11):575-90. PubMed ID: 17960326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Present concepts and future outlook: function of peroxisome proliferator-activated receptors (PPARs) for pathogenesis, progression, and therapy of cancer.
    Sertznig P; Seifert M; Tilgen W; Reichrath J
    J Cell Physiol; 2007 Jul; 212(1):1-12. PubMed ID: 17443682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peroxisome Proliferator-activated Receptors as Potential Targets for Carcinogenic Activity of Polychlorinated Biphenyls: A Computational Perspective.
    Sheikh IA; Khweek AA; Beg MA
    Anticancer Res; 2016 Nov; 36(11):6117-6124. PubMed ID: 27793940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors.
    Michalik L; Auwerx J; Berger JP; Chatterjee VK; Glass CK; Gonzalez FJ; Grimaldi PA; Kadowaki T; Lazar MA; O'Rahilly S; Palmer CN; Plutzky J; Reddy JK; Spiegelman BM; Staels B; Wahli W
    Pharmacol Rev; 2006 Dec; 58(4):726-41. PubMed ID: 17132851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthetic and natural Peroxisome Proliferator-Activated Receptor (PPAR) agonists as candidates for the therapy of the metabolic syndrome.
    Tan CK; Zhuang Y; Wahli W
    Expert Opin Ther Targets; 2017 Mar; 21(3):333-348. PubMed ID: 28092722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blocking the peroxisome proliferator-activated receptor (PPAR): an overview.
    Ammazzalorso A; De Filippis B; Giampietro L; Amoroso R
    ChemMedChem; 2013 Oct; 8(10):1609-16. PubMed ID: 23939910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The role of peroxisome proliferator-activated receptors (PPAR) in carcinogenesis].
    Knapp P; Jarzabek K; Błachnio A; Zbroch T
    Ginekol Pol; 2006 Aug; 77(8):643-51. PubMed ID: 17076197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Affinity-based separation methods for the study of biological interactions: The case of peroxisome proliferator-activated receptors in drug discovery.
    Temporini C; Brusotti G; Pochetti G; Massolini G; Calleri E
    Methods; 2018 Aug; 146():12-25. PubMed ID: 29462658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.